Tag: nitrosamines

Identifying Potential Nitrosamine Sources During Submission Support: A Risk Mitigation Playbook Nitrosamines have emerged as a significant quality concern in the pharmaceutical industry, particularly concerning the integrity of raw materials.…

Addressing Weak Supplier Nitrosamine Control During Audits: A Playbook for Pharmaceutical Professionals In recent years, the presence of nitrosamines in pharmaceuticals has raised significant concerns regarding product safety and compliance.…

Navigating Incomplete Nitrosamine Risk Assessment during Regulatory Inspections In the ever-evolving pharmaceutical landscape, ensuring compliance during regulatory inspections is crucial. One prominent challenge is managing incomplete nitrosamine risk assessments, particularly…

Navigating Incomplete Nitrosamine Risk Assessments During Supplier Audits The increasing scrutiny of nitrosamines in pharmaceutical manufacturing is prompting organizations to reassess their risk management strategies, particularly during supplier audits. A…

Risk Mitigation and Control Strategies for Analytical Method Sensitivity Issues Highlighted During Supplier Audits Pharmaceutical manufacturing professionals often face challenges when analytical methods used for raw material assessments are deemed…

Actionable Strategies for Inadequate Risk Mitigation Plans During Ongoing Surveillance of Nitrosamine Findings In the complex landscape of pharmaceutical manufacturing, the presence of nitrosamines in raw materials poses significant challenges.…

Addressing Inadequate Risk Mitigation Plans During Nitrosamine Risk Assessments The increasing scrutiny surrounding nitrosamines in pharmaceutical products necessitates robust risk assessment and mitigation strategies. When a risk mitigation plan is…

Addressing Weak Supplier Nitrosamine Control During Submission Support: A Comprehensive Playbook The increasing scrutiny of nitrosamine impurities in pharmaceuticals has led to heightened expectations for supplier control measures. Regulatory bodies…

Actionable Guide for Managing Nitrosamine Risks Uncovered in Regulatory Inspections In the highly regulated landscape of pharmaceutical manufacturing, the identification of potential nitrosamine sources during regulatory inspections poses a significant…

Managing Regulatory Queries on Nitrosamines During Risk Assessment to Prevent Product Recall The detection of nitrosamines in pharmaceutical products has led to increased scrutiny from regulators such as the FDA,…

Optimizing Analytical Method Sensitivity for Nitrosamine Risk Assessment Nitrosamines continue to be a point of sensitivity in the pharmaceutical sector, creating challenges in raw material management and quality control. As…

Nitrosamine Risk Assessment During Supplier Audits: Ensuring Completeness for Compliance Nitrosamine contamination has emerged as a critical quality issue, prompting heightened scrutiny from regulatory agencies such as the FDA and…